Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander H Glassman

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Ethnicity & Disease|May 2, 2008
Smokers' response to combination bupropion, nicotine patch, and counseling treatment by race/ethnicityLirio S Covey, Maria Botello-Harbaum, Alexander H Glassman, et al.
Addiction (Abingdon, England)|July 13, 2007
A randomized trial of bupropion and/or nicotine gum as maintenance treatment for preventing smoking relapseLirio S Covey, Alexander H Glassman, Huiping Jiang, et al.
The American Journal of Cardiology|November 26, 2003
Influence of depression and effect of treatment with sertraline on quality of life after hospitalization for acute coronary syndromeJ Robert Swenson, Christopher M O'Connor, David Barton, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 10, 2003
Enhanced platelet/endothelial activation in depressed patients with acute coronary syndromes: evidence from recent clinical trialsVictor L Serebruany, Alexander H Glassman, Alex I Malinin, et al.
The American Journal of Psychiatry|June 4, 2005
Relationship between release of platelet/endothelial biomarkers and plasma levels of sertraline and N-desmethylsertraline in acute coronary syndrome patients receiving SSRI treatment for depressionVictor L Serebruany, Raymond F Suckow, Thomas B Cooper, et al.
Circulation|August 13, 2003
Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet SubstudyVictor L Serebruany, Alexander H Glassman, Alex I Malinin, et al.
JAMA|August 10, 2002
Sertraline treatment of major depression in patients with acute MI or unstable anginaAlexander H Glassman, Christopher M O'Connor, Robert M Califf, et al.
Psychosomatic Medicine|October 3, 2006
Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute Working Group ReportKarina W Davidson, David J Kupfer, J Thomas Bigger, et al.
Biological Psychiatry|August 9, 2005
Mood disorders in the medically ill: scientific review and recommendationsDwight L Evans, Dennis S Charney, Lydia Lewis, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Ethnicity & Disease|May 2, 2008
Smokers' response to combination bupropion, nicotine patch, and counseling treatment by race/ethnicityLirio S Covey, Maria Botello-Harbaum, Alexander H Glassman, et al.
Addiction (Abingdon, England)|July 13, 2007
A randomized trial of bupropion and/or nicotine gum as maintenance treatment for preventing smoking relapseLirio S Covey, Alexander H Glassman, Huiping Jiang, et al.
The American Journal of Cardiology|November 26, 2003
Influence of depression and effect of treatment with sertraline on quality of life after hospitalization for acute coronary syndromeJ Robert Swenson, Christopher M O'Connor, David Barton, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 10, 2003
Enhanced platelet/endothelial activation in depressed patients with acute coronary syndromes: evidence from recent clinical trialsVictor L Serebruany, Alexander H Glassman, Alex I Malinin, et al.
The American Journal of Psychiatry|June 4, 2005
Relationship between release of platelet/endothelial biomarkers and plasma levels of sertraline and N-desmethylsertraline in acute coronary syndrome patients receiving SSRI treatment for depressionVictor L Serebruany, Raymond F Suckow, Thomas B Cooper, et al.
Circulation|August 13, 2003
Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet SubstudyVictor L Serebruany, Alexander H Glassman, Alex I Malinin, et al.
JAMA|August 10, 2002
Sertraline treatment of major depression in patients with acute MI or unstable anginaAlexander H Glassman, Christopher M O'Connor, Robert M Califf, et al.
Psychosomatic Medicine|October 3, 2006
Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute Working Group ReportKarina W Davidson, David J Kupfer, J Thomas Bigger, et al.
Biological Psychiatry|August 9, 2005
Mood disorders in the medically ill: scientific review and recommendationsDwight L Evans, Dennis S Charney, Lydia Lewis, et al.
Pageof 2